Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, Check Point Software Technologies Ltd. (CHKP) has a Wall Street consensus price target of $207.93, based on estimates from 62 covering analysts. With the stock currently trading at $152.07, this represents a potential upside of +36.7%. The company has a market capitalization of $16.48B.
Analyst price targets range from a low of $180.00 to a high of $240.00, representing a 29% spread in expectations. The median target of $210.00 aligns closely with the consensus average.
The current analyst consensus rating is Hold, with 28 analysts rating the stock as a Buy or Strong Buy,30 rating it Hold, and 4 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, CHKP trades at a trailing P/E of 20.4x and forward P/E of 14.6x. The forward PEG ratio of 2.22 reflects a premium valuation. Analysts expect EPS to grow +13.1% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $223.22, with bear and bull scenarios of $150.88 and $291.95 respectively. Model confidence stands at 82/100, indicating high predictability in the company's fundamentals.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CHKP stacks up against sector leader NVIDIA Corporation.
Start ComparisonThe consensus Wall Street price target for CHKP is $207.93, representing 36.7% upside from the current price of $152.07. With 62 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CHKP has a consensus rating of "Hold" based on 62 Wall Street analysts. The rating breakdown is mixed, with 30 Hold ratings making up the largest segment. The consensus 12-month price target of $207.93 implies 36.7% upside from current levels.
With a forward P/E of 14.5805x, CHKP trades at a relatively low valuation. The consensus target of $207.93 implies 36.7% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $240 for CHKP, while the most conservative target is $180. The consensus of $207.93 represents the median expectation. Our quantitative valuation model projects a bull case target of $292 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CHKP is heavily covered by Wall Street, with 62 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 28 have Buy ratings, 30 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CHKP stock forecast based on 62 Wall Street analysts shows a consensus price target of $207.93, with estimates ranging from $180 (bear case) to $240 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $223, with bear/bull scenarios of $151/$292.
Our quantitative valuation model calculates CHKP's fair value at $223 (base case), with a bear case of $151 and bull case of $292. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 82/100.
CHKP trades at a forward P/E ratio of 14.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 20.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CHKP, with a "Hold" consensus rating and $207.93 price target (36.7% upside). 28 of 62 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CHKP analyst price targets range from $180 to $240, a 29% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $207.93 consensus represents the middle ground. Our model's $151-$292 range provides an independent fundamental perspective.